Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Zuraiz ChaudharySEE REMARKS | Turn TherapeuticsTTRX | Open-market buy | 25/12/12 | 25/12/12 | 2,500 sh | $3.50 | $8,750 | +25.0% |
Arthur F. GoldenDirector | Turn TherapeuticsTTRX | Open-market buy | 25/11/24 | 25/11/25 | 9,868 sh | $3.44 | $33,945.92 | +19.5% |
Arthur F. GoldenDirector | Turn TherapeuticsTTRX | Open-market buy | 25/11/21 | 25/11/24 | 20,532 sh | $2.87 | $58,926.84 | +68.0% |
Turn TherapeuticsTTRX | Open-market buy | 25/11/20–25/11/21 | 25/11/21 | 2,450 sh2 trades | $2.89avg. | $7,074.5 | +32.5% | |
Zuraiz ChaudharySEE REMARKS | Turn TherapeuticsTTRX | Open-market buy | 25/11/17 | 25/11/17 | 2,500 sh | $3.62 | $9,050 | +49.5% |
Abraham ChesedOther | Turn TherapeuticsTTRX | Open-market buy | 25/10/23 | 25/10/29 | 14,286 sh | $4.60 | $65,715.6 | +1.0% |
Arthur F. GoldenDirector | Turn TherapeuticsTTRX | Open-market buy | 25/10/23 | 25/10/23 | 20,202 sh | $4.95 | $99,999.9 | +202.0% |
Zuraiz ChaudharySEE REMARKS | Turn TherapeuticsTTRX | Open-market buy | 25/10/23 | 25/10/23 | 5,050 sh | $4.95 | $24,997.5 | No record |